tolbutamide has been researched along with nadp in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (55.00) | 18.7374 |
| 1990's | 3 (15.00) | 18.2507 |
| 2000's | 5 (25.00) | 29.6817 |
| 2010's | 1 (5.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ammon, HP | 2 |
| Gilon, P; Henquin, JC | 1 |
| Iber, FL; Kostelnik, ME | 1 |
| Gaskin, JH; Hollifield, G; Lindsay, RW; Owen, JA | 1 |
| Dempsey, ME | 1 |
| Hostetler, KY; Williams, HR | 1 |
| Ashcroft, SJ; Randle, PJ | 1 |
| Gabbay, KH; Tze, WJ | 1 |
| Gylfe, E; Hellman, B; Sehlin, J; Täljedal, B | 1 |
| Couturier, E; Kawazu, S; Malaisse, WJ; Sener, A | 1 |
| Ammon, HP; Grimm, A; Hagenloh, I; Händel, M; Lutz, S; Wagner-Teschner, D | 1 |
| Gilon, P; Henquin, JC; Lambillotte, C | 1 |
| Dong, MS; Gillam, EM; Guengerich, FP; Johnson, WW; Shimada, T; Yamazaki, H | 1 |
| Feng, WW; Lin, CC; Nomeir, AA; Palamanda, J | 1 |
| Garcia-Barrado, MJ; Gilon, P; Henquin, JC; Nenquin, M; Ravier, MA; Rolland, JF | 1 |
| Chaffard, G; Maechler, P; Merglen, A; Rubi, B; Theander, S; Wollheim, CB | 1 |
| Burns, CJ; Evans, ND; Jones, PM; Milne, HM; Persaud, SJ; Pickup, J; Squires, PE | 1 |
| Beauvois, MC; Cheng-Xue, R; Gilon, P; Guiot, Y; Henquin, JC; Mattart, L; Quoix, N; Zeinoun, Z | 1 |
| Di Nardo, G; Gilardi, G; Goyal, A; Sideri, A; Tsotsou, GE | 1 |
1 review(s) available for tolbutamide and nadp
| Article | Year |
|---|---|
Interaction of sulfonylurea with the pancreatic B-cell.
Topics: 4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid; Adenosine Triphosphate; Amino Acids; Animals; Calcimycin; Calcium; Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone; Fatty Acids; Glucose; Glyburide; Humans; Islets of Langerhans; Lasalocid; Membrane Potentials; NADP; Phenylbutazone; Rubidium; Serum Albumin; Sulfonylurea Compounds; Time Factors; Tolbutamide | 1984 |
19 other study(ies) available for tolbutamide and nadp
| Article | Year |
|---|---|
Effect of tolbutamide on aminophylline-, 3,5-AMP-dibutyrate- or glucagon-induced insulin release from pancreatic islets after impairment of pyridine nucleotide metabolism caused by 6-aminonicotinamide (6-AN).
Topics: 6-Aminonicotinamide; Aminophylline; Animals; Bucladesine; Female; Glucagon; Glucose; In Vitro Techniques; Insulin; Insulin Secretion; Islets of Langerhans; Male; NAD; NADP; Niacinamide; Rats; Tolbutamide | 1975 |
Influence of membrane potential changes on cytoplasmic Ca2+ concentration in an electrically excitable cell, the insulin-secreting pancreatic B-cell.
Topics: Animals; Arginine; Azides; Calcium; Cytosol; Diazoxide; Female; Glucose; In Vitro Techniques; Islets of Langerhans; Kinetics; Mannoheptulose; Membrane Potentials; Mice; Mice, Inbred Strains; NAD; NADP; Oscillometry; Potassium; Spectrometry, Fluorescence; Tolbutamide | 1992 |
Correlation of alcohol and tolbutamide blood clearance rates with microsomal alcohol-metabolizing enzyme activity.
Topics: Adult; Alcohol Oxidoreductases; Alcoholism; Biopsy; Chronic Disease; Ethanol; Half-Life; Humans; Injections, Intravenous; Male; Metabolic Clearance Rate; Microsomes, Liver; Middle Aged; NADP; Tolbutamide | 1973 |
[Stimulation of insulin secretion by tolbutamide. Studies on experimental diabetes].
Topics: Animals; Diabetes Mellitus; Drug Synergism; Glucose; In Vitro Techniques; Insulin; Insulin Secretion; Islets of Langerhans; Models, Biological; NADP; Niacinamide; Oxidation-Reduction; Rats; Stimulation, Chemical; Tolbutamide | 1973 |
Response of human adipose tissue to endogenous serum insulin-like activity in vitro.
Topics: Adipose Tissue; Animals; Blood; Carbon Isotopes; Diabetes Mellitus; Epididymis; Humans; In Vitro Techniques; Insulin; Male; NADP; Rats; Tolbutamide | 1967 |
Inhibition of lipid biosynthesis.
Topics: Acetates; Animals; Anticholesteremic Agents; Antimetabolites; Chlorpropamide; Cholestanes; Cholesterol; Chromatography; Depression, Chemical; Hydroxysteroid Dehydrogenases; Hypolipidemic Agents; Lipids; Liver; Mevalonic Acid; NADP; Phenformin; Rats; Squalene; Sterols; Tolbutamide; Tritium | 1968 |
Effects of hyperglycemia, tolbutamide and glucagon on the pathways of glucose oxidation in the goosefish islet in vitro.
Topics: Animals; Carbon Isotopes; Citric Acid Cycle; Fishes; Glucagon; Glucose; Hyperglycemia; Islets of Langerhans; NAD; NADP; Nucleotides; Oxygen; Pyridines; Tolbutamide | 1970 |
Enzymes of glucose metabolism in normal mouse pancreatic islets.
Topics: Animals; Carbon Isotopes; Citrates; Glucokinase; Gluconates; Glucose; Glucose-6-Phosphatase; Glucosephosphate Dehydrogenase; Heptoses; Hexokinase; Hexosephosphates; In Vitro Techniques; Islets of Langerhans; Isocitrate Dehydrogenase; Kinetics; Ligases; Malate Dehydrogenase; Mannose; Mice; NADP; Phosphogluconate Dehydrogenase; Pyruvates; Tolbutamide | 1970 |
Inhibition of glucose-induced release of insulin by aldose reductase inhibitors.
Topics: Alcohol Oxidoreductases; Animals; Chromatography, DEAE-Cellulose; Chromatography, Gel; Colchicine; Depression, Chemical; Drug Antagonism; Glucose; Glucuronates; Glutarates; Insulin; Islets of Langerhans; Kinetics; NADP; Pancreas; Perfusion; Rats; Rats, Inbred Strains; Sorbitol; Sugar Alcohols; Tolbutamide | 1972 |
Metabolic, cationic and secretory effects of hypoglycemic sulfonylureas in pancreatic islets.
Topics: Animals; Calcium; Female; Hypoglycemic Agents; In Vitro Techniques; Insulin; Insulin Secretion; Islets of Langerhans; NAD; NADP; Rats; Rubidium; Sodium; Sulfonylurea Compounds; Theophylline; Tolbutamide | 1980 |
Islet glutathione and insulin release.
Topics: Animals; Chloromercuribenzoates; Female; Glucose; Glutathione; In Vitro Techniques; Insulin; Insulin Secretion; Islets of Langerhans; Male; NADP; Oxidation-Reduction; Rats; Tolbutamide | 1980 |
Direct glucocorticoid inhibition of insulin secretion. An in vitro study of dexamethasone effects in mouse islets.
Topics: Animals; Arginine; B-Lymphocytes; Bucladesine; Calcium; Cells, Cultured; Cyclic AMP; Dexamethasone; Dose-Response Relationship, Drug; Glucocorticoids; Glucose; Inositol Phosphates; Insulin; Insulin Secretion; Islets of Langerhans; Male; Mice; Mice, Inbred Strains; NADP; Oxidation-Reduction; Pertussis Toxin; Phorbol Esters; Potassium; Receptors, Glucocorticoid; Tolbutamide; Virulence Factors, Bordetella | 1997 |
Reconstitution of recombinant cytochrome P450 2C10(2C9) and comparison with cytochrome P450 3A4 and other forms: effects of cytochrome P450-P450 and cytochrome P450-b5 interactions.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; Chlorzoxazone; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Cytochromes b5; Escherichia coli; Ethanolamines; Humans; Hydroxylation; Mixed Function Oxygenases; Mutation; NADP; Nifedipine; Oxidation-Reduction; Phospholipids; Recombinant Proteins; Testosterone; Theophylline; Tolbutamide; Warfarin | 1997 |
Stimulation of tolbutamide hydroxylation by acetone and acetonitrile in human liver microsomes and in a cytochrome P-450 2C9-reconstituted system.
Topics: Acetone; Acetonitriles; Aryl Hydrocarbon Hydroxylases; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2C9; Cytochrome P-450 Enzyme System; Female; Humans; Hydroxylation; Hypoglycemic Agents; Male; Microsomes, Liver; NADP; Solvents; Steroid 16-alpha-Hydroxylase; Steroid Hydroxylases; Tolbutamide | 2000 |
Inhibition of protein synthesis sequentially impairs distinct steps of stimulus-secretion coupling in pancreatic beta cells.
Topics: Animals; Calcium; Cycloheximide; Cytosol; Glucose; Glycolysis; In Vitro Techniques; Insulin; Insulin Secretion; Islets of Langerhans; Kinetics; Membrane Potentials; Mice; Mice, Inbred Strains; NAD; NADP; Potassium; Potassium Channels; Protein Synthesis Inhibitors; Tolbutamide | 2001 |
Glucose sensitivity and metabolism-secretion coupling studied during two-year continuous culture in INS-1E insulinoma cells.
Topics: Adenosine Triphosphate; Animals; Calcium; Cell Differentiation; Cell Division; Cytosol; Diazoxide; Electric Conductivity; Electrophysiology; Glucose; Insulin; Insulin Secretion; Insulinoma; Islets of Langerhans; Membrane Potentials; Mitochondria; NADP; Pancreatic Neoplasms; Patch-Clamp Techniques; Potassium Chloride; Rats; Tolbutamide; Tumor Cells, Cultured | 2004 |
Uncoupling of nutrient metabolism from insulin secretion by overexpression of cytosolic phospholipase A(2).
Topics: Animals; Calcium; Cell Line; Glucose; Insulin; Insulin Secretion; Ion Channels; Islets of Langerhans; Membrane Transport Proteins; Mitochondrial Proteins; NAD; NADP; Phospholipases A; Potassium Chloride; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tolbutamide; Transfection; Uncoupling Protein 2 | 2005 |
Glucose and pharmacological modulators of ATP-sensitive K+ channels control [Ca2+]c by different mechanisms in isolated mouse alpha-cells.
Topics: Animals; Azides; Calcium; Diazoxide; gamma-Aminobutyric Acid; Glucagon-Secreting Cells; Glucose; Insulin-Secreting Cells; KATP Channels; Mice; Mice, Inbred Strains; NADP; Nimodipine; Tolbutamide | 2009 |
Identification of mutant Asp251Gly/Gln307His of cytochrome P450 BM3 for the generation of metabolites of diclofenac, ibuprofen and tolbutamide.
Topics: Asparagine; Bacillus megaterium; Catalysis; Cytochrome P-450 Enzyme System; Diclofenac; Drug Discovery; Escherichia coli; Glutamine; Glycine; Histidine; Humans; Hydroxylation; Ibuprofen; NADP; NADPH-Ferrihemoprotein Reductase; Oxidation-Reduction; Tolbutamide | 2012 |